Life360 director exercises options and sells shares

Q: What did Life360 (LIF) director Brit Morin report in this Form 4?

Brit Morin reported exercising stock options for 9,765 shares of Life360 common stock and selling 15,582 shares on August 10, 2026, combining option exercises with an open-market sale.

Q: How many Life360 (LIF) shares did Brit Morin sell and at what price?

Brit Morin reported selling 15,582 shares of Life360 common stock at a price of $65.00 per share. The transaction is coded as a sale of non-derivative common stock.

Q: What options did Brit Morin exercise in Life360 (LIF) on August 10, 2026?

She exercised options covering 8,021 shares at $2.15 per share and 1,744 shares at $8.19 per share, converting them into the same number of Life360 common shares before the reported sale.

Life360, Inc. director Brit Morin reported an option exercise-and-sale sequence on August 10, 2026.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Life360, Inc. director Brit Morin reported an option exercise-and-sale sequence on August 10, 2026. She exercised stock options for a total of 9,765 shares of common stock at exercise prices of $2.15 and $8.19 per share, then sold 15,582 shares of common stock at $65.00 per share. A footnote states these transactions were made under a Rule 10b5-1 trading plan adopted on March 13, 2026, and that the reporting person’s holdings include 4,636 restricted stock units representing contingent rights to receive common shares upon vesting.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 5 txns

Insider Morin Brit

Role Director

Sold 15,582 shs ($1.01M)

Approx. gross sale proceeds $1.01M

Approx. exercise cost $32K

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy) ^{F1, F3}	8,021	$0.00	$0.00
Exercise	Stock Option (right to buy) ^{F1, F3}	1,744	$0.00	$0.00
Exercise	Common stock ^{F1, F2}	8,021	$2.15	$17K
Exercise	Common stock ^{F1, F2}	1,744	$8.19	$14K
Sale	Common stock ^{F1, F2}	15,582	$65.00	$1.01M

Holdings After Transaction: Stock Option (right to buy) — 74,276 contracts (Direct); Common stock — 14,340 shares (Direct)

Footnotes (3)

F1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.
F2. Includes 4,636 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
F3. The stock option is fully vested and exercisable.

Key Figures

Shares sold: 15,582 shares Sale price: $65.00 per share Options exercised (total shares): 9,765 shares +3 more

6 metrics

Shares sold 15,582 shares Common stock sale on August 10, 2026 at $65.00 per share

Sale price $65.00 per share Price for 15,582 Life360 common shares sold

Options exercised (total shares) 9,765 shares Stock options converted into common stock on August 10, 2026

Option exercise price 1 $2.15 per share Exercise price for 8,021-share stock option, expiring January 24, 2028

Option exercise price 2 $8.19 per share Exercise price for 1,744-share stock option, expiring May 20, 2028

Restricted stock units 4,636 units Each unit represents a contingent right to one common share upon vesting

Key Terms

Rule 10b5-1 trading plan, Stock Option (right to buy, restricted stock units, Exercise or conversion of derivative security

4 terms

Rule 10b5-1 trading plan regulatory

"The transaction was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Stock Option (right to buy financial

"security_title: Stock Option (right to buy)"

restricted stock units financial

"Includes 4,636 restricted stock units, each of which represents a contingent right"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Exercise or conversion of derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Life360 (LIF) director Brit Morin report in this Form 4?

Brit Morin reported exercising stock options for 9,765 shares of Life360 common stock and selling 15,582 shares on August 10, 2026, combining option exercises with an open-market sale.

How many Life360 (LIF) shares did Brit Morin sell and at what price?

Brit Morin reported selling 15,582 shares of Life360 common stock at a price of $65.00 per share. The transaction is coded as a sale of non-derivative common stock.

What options did Brit Morin exercise in Life360 (LIF) on August 10, 2026?

She exercised options covering 8,021 shares at $2.15 per share and 1,744 shares at $8.19 per share, converting them into the same number of Life360 common shares before the reported sale.

Was Brit Morin’s Life360 (LIF) stock sale under a Rule 10b5-1 plan?

Yes. A footnote states the transactions were effected under a Rule 10b5-1 trading plan adopted on March 13, 2026, providing for automatic sales based on predetermined criteria.

Does the Form 4 mention restricted stock units for Life360 (LIF)?

Yes. A footnote states the reporting person’s holdings include 4,636 restricted stock units, each representing a contingent right to receive one Life360 common share upon vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 08/12/2026 - 04:07 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morin Brit

(Last)

(First)

(Middle)

C/O LIFE360, INC.

1900 SOUTH NORFOLK STREET, SUITE 310

(Street)

SAN MATEO

CALIFORNIA

94403

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common stock	08/10/2026		M⁽¹⁾		8,021	A	$2.15	28,178⁽²⁾	D
Common stock	08/10/2026		M⁽¹⁾		1,744	A	$8.19	29,922⁽²⁾	D
Common stock	08/10/2026		S⁽¹⁾		15,582	D	$65	14,340⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$2.15	08/10/2026		M⁽¹⁾			8,021	⁽³⁾	01/24/2028	Common stock	8,021	$0	68,173	D
Stock Option (right to buy)	$8.19	08/10/2026		M⁽¹⁾			1,744	⁽³⁾	05/20/2028	Common stock	1,744	$0	6,103	D

Explanation of Responses:

1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company.

2. Includes 4,636 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

3. The stock option is fully vested and exercisable.

Remarks:

	/s/ Jay Sood, as Attorney-in-Fact	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR